Management of neuroendocrine neoplasia represents a clinical challenge because of its
late presentation, lack of treatment options, and limitations in present imaging modalities …

The management of neuroendocrine neoplasia remains a perplexing problem because of
the lack of knowledge of the biology of the disease, its late presentation, the relative …

The identification of accurate harbingers of disease status and therapeutic efficacy are
critical requirements in precise diagnosis and effective management. Initially, tissue analysis …

Neuroendocrine tumours (NETs) are neoplasms that arise from neuroendocrine cells.
Neuroendocrine cells and their tumours can secrete a wide range of amines and …

The overall sensitivity and specificity of urinary 5-HIAA in the presence of the carcinoid
syndrome is of the order of 70 and 90%, respectively [1, 2]. Midgut carcinoids are most liable …

Background Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are a
complex family of tumors of widely variable clinical behavior. The World Health Organization …

Epithelial neuroendocrine tumors (NETs) have been the subject of much debate regarding
their optimal classification. Although multiple systems of nomenclature, grading, and staging …

Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms with distinct
biological behaviors, depending on the site of origin and the degree of tumor proliferation …

Neuroendocrine neoplasms (NENs), also called neuroendocrine tumors (NETs), and
generically referred to as “carcinoids,” represent a spectrum of tumors with a diverse range …

Background: The rarity of neuroendocrine malignancies limits the ability to develop new
therapies and thus a better understanding of the underlying biology is critical. Methods …